These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 19840014

  • 1. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Klein EA.
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [Abstract] [Full Text] [Related]

  • 2. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J.
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [Abstract] [Full Text] [Related]

  • 3. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A, Pfister D.
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [Abstract] [Full Text] [Related]

  • 4. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ, Scheitlin W, Heidenreich A, Laguna MP, Janetschek G.
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [Abstract] [Full Text] [Related]

  • 5. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J.
    J Clin Oncol; 2005 Apr 20; 23(12):2781-8. PubMed ID: 15837993
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.
    Ai Zheng; 2008 Dec 20; 27(12):1302-6. PubMed ID: 19079998
    [Abstract] [Full Text] [Related]

  • 7. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5597-602. PubMed ID: 18065732
    [Abstract] [Full Text] [Related]

  • 8. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ, Murray N, Coppin C, Kollmannsberger C, Man A, Chi KN.
    J Urol; 2005 Dec 10; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D, Ondrusova M, Hornak M, Matoska J.
    Neoplasma; 2007 Dec 10; 54(5):437-42. PubMed ID: 17688374
    [Abstract] [Full Text] [Related]

  • 11. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP.
    BJU Int; 2010 Sep 10; 106(6):779-85. PubMed ID: 20089110
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group.
    J Clin Oncol; 2008 Jun 20; 26(18):2966-72. PubMed ID: 18458040
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A, Carver BS, Stasi J, Bajorin DF, Motzer RJ, Bosl GJ, Sheinfeld J.
    Cancer; 2008 Feb 15; 112(4):800-5. PubMed ID: 18172902
    [Abstract] [Full Text] [Related]

  • 17. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP.
    Hematol Oncol Clin North Am; 1991 Dec 15; 5(6):1127-42. PubMed ID: 1663937
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.
    Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A.
    Urology; 2004 Mar 15; 63(3):550-5. PubMed ID: 15028456
    [Abstract] [Full Text] [Related]

  • 19. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH, Stein JP, Skinner DG.
    Expert Rev Anticancer Ther; 2005 Feb 15; 5(1):75-85. PubMed ID: 15757440
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.